Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Findi earnings growth capitalises on India’s reliance on ATMs
    • News

    Findi earnings growth capitalises on India’s reliance on ATMs

    In rural India, where the fintech infrastructure is still developing, there is a dire need for companies to set up shop with digital payment services. But until that happens, Findi (ASX: FND), formerly Vortiv, is witnessing substantial earnings growth via transaction fees charged throughout their ATM network.  With its country-wide ATM rollout with the Central

    Read More
    Public
  • Incannex plugs Eurofin Scientific to kick off research into newly discovered cannabinoid
    • News

    Incannex plugs Eurofin Scientific to kick off research into newly discovered cannabinoid

    The pharma company developing therapies for unmet needs with the use of medicinal cannabinoids and psychedelics, Incannex Healthcare (ASX: IHL), has been on the move recently and has engaged Eurofins Scientific to manufacture the Company’s ReneCann therapeutic topical application drug. Eurofins Scientific, which is a French group of laboratories based out of Luxemburg, is a

    Read More
    Public
  • Neolender Wisr lands approval from another Big 4 to give Aussies relief from rising interest rates
    • News

    Neolender Wisr lands approval from another Big 4 to give Aussies relief from rising interest rates

    High interest rates have left Aussies in a lurch, postponing their grand purchases and consolidating their debts. A downside of debt consolidation is that you could end up paying a greater interest rate. That’s why people are counting on non-traditional banks, like neo-lender Wisr (ASX: WZR), which provides interest rates based on an individual’s credit

    Read More
    Public
  • Platinum Asset Management identify value opportunity in Pharmaxis with $1.9m stake
    • News

    Platinum Asset Management identify value opportunity in Pharmaxis with $1.9m stake

    When it comes to biotech investing, the value opportunities in Australia attract many of the world’s smartest investors. Amongst them, Platinum Asset Management (ASX: PTM) has joined a growing list of institutions taking a substantial stake in a little-known Aussie biotech set to announce hugely-anticipated clinical trial results within the next few months.  With more

    Read More
    Public
  • KneoMedia and NYC Department of Education deploys 40,000 units of edutech software to public schools
    • News

    KneoMedia and NYC Department of Education deploys 40,000 units of edutech software to public schools

    The beginning of FY23 has been an appreciable sales period for online education provider KneoMedia (ASX: KNM) so far. The Company had just deployed 40,000 units of Dell Chromebooks linked to the KneoWorld platform into 11 school districts located across New York City. Students across school districts in all five Boroughs now have access to

    Read More
    Public
  • BWX calls on advisors for FY22 financials while shareholders locked in suspension since August, cyberattack too
    • News

    BWX calls on advisors for FY22 financials while shareholders locked in suspension since August, cyberattack too

    When auditors are unable to get around your financial statements for four months, you know something is off big time. But the question on investors’ mind is: how bad is it? Natural beauty and wellness company BWX (ASX: BWX), known for its brands Sukin, Go-To and Mineral Fusion, is yet to disclose. After releasing a

    Read More
    Public
  • «
  • ‹
  • 306
  • 307
  • 308
  • 309
  • 310
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.